Tengion News
Most Popular Tengion Story
Emerging Drug Developer: Tengion
For most up-and-coming biotech companies, just getting a therapeutic candidate through a proof-of-concept trial and into a licensing deal is a big enough challenge to consume all of their planning Read more...
Latest Headlines
- January 20, 2011
- April 9, 2010
- April 6, 2010
- December 28, 2009
- November 19, 2008
- October 19, 2007
- October 18, 2007
- October 15, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
